Dr. Brenda Herschbach Jarrell has been recognized by Lexology Index (formerly Who’s Who Legal) in its Thought Leaders USA 2026 guide for her work in Life Sciences-Patent Litigation. The Lexology Index research process involves qualitative and quantitative analysis of a range of relevant data points to ensure a rigorous evaluation framework, including input from corporate counsel or other clients who have worked closely with the nominees. Brenda is chair of Choate’s Life Sciences Group where she represents companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them, guiding IP protection and competitive positioning strategies, negotiating strategic transactions, and providing creative solutions to IP and technology-related challenges. Her extensive technical credentials make her well-versed in a wide variety of technologies in the biotech, pharmaceutical, and specialty chemical industries. Brenda has been named a “Lawyer of the Year” by LMG Life Sciences and Best Lawyers, an “Intellectual Property Trailblazer” by the National Law Journal, a “Top Woman of Law” by Massachusetts Lawyers Weekly, a “World Leading Patent Practitioner” by IAM Patent 1000, an “IP Star” and in the “Top 250 Women in IP” by Managing Intellectual Property, a “Litigation Star” by Benchmark Litigation, a “Life Sciences Star” by LMG Life Sciences, and is regularly recognized by Chambers USA and The Legal 500.